STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] Voyager Therapeutics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

VYGR: A holder filed a Form 144 notice to sell 7,666 shares of common stock. The filing lists an aggregate market value of $36,633.51 and an approximate sale date of 10/03/2025, with sales through Fidelity Brokerage Services LLC on NASDAQ.

The shares were acquired on 10/01/2025 via restricted stock vesting from the issuer as compensation. Shares outstanding were 55,468,806; this is a baseline figure, not the amount being sold.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Voyager Therapeutics Inc

NASDAQ:VYGR

VYGR Rankings

VYGR Latest News

VYGR Latest SEC Filings

VYGR Stock Data

224.07M
46.50M
16.52%
59.95%
5.31%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
LEXINGTON